Thromboplastin reagents and methods for preparing and using such reagents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6391609
SERIAL NO

09413683

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are mammalian thromboplastin reagents and methods for preparing such reagents. The thromboplastin reagents are suitable for use in prothrombin-time (PT) assays, and offer improved sensitivities with acceptable PT-normal times. Contaminating proteins--particularly plasma clotting factors--are separated from a thromboplastin solution by a membrane permeation protocol, in which the thromboplastin solution is exposed to a semipermeable membrane and clotting factors are allowed to pass from the thromboplastin solution through the membrane, while Tissue Factor is retained in the thromboplastin solution. In a preferred method, one or more contaminating clotting factors are separated by diafiltration from a NaCl/Na.sub.3 Citrate thromboplastin extract of mammalian tissue, and the purified thromboplastin extract is combined with Ca.sup.++ ions to form a thromboplastin reagent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TCOAG IRELAND LIMITEDDUBLIN 2

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Goldford, Marc D Ballwin, MO 1 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation